株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオバンキング市場:試料タイプ別、バイオバンクタイプ別、オーナーシップ別、用途別市場:世界の機会分析と業界予測

Biobanking Market by Specimen Type, Type of Biobank, Ownership, and Application - Global Opportunity Analysis and Industry Forecast, 2018-2025

発行 Allied Market Research 商品コード 660952
出版日 ページ情報 英文 205 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.43円で換算しております。
Back to Top
バイオバンキング市場:試料タイプ別、バイオバンクタイプ別、オーナーシップ別、用途別市場:世界の機会分析と業界予測 Biobanking Market by Specimen Type, Type of Biobank, Ownership, and Application - Global Opportunity Analysis and Industry Forecast, 2018-2025
出版日: 2018年06月01日 ページ情報: 英文 205 Pages
概要

当レポートでは、世界のバイオバンキング市場について調査し、市場の動向と試料タイプ別、バイオバンクタイプ別、オーナーシップ別、用途別、地域別動向、および市場に参入する企業のプロファイルをまとめています。

第1章 イントロダクション

  • レポートの内容
  • ステークホルダーの利益
  • 主な市場セグメント
  • 調査方法

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
  • 主要参入企業のポジショニング
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
    • 影響分析

第4章 試料タイプ別市場

  • 概要
  • 血液製剤
  • 固形組織
  • 細胞株
  • その他

第5章 バイオバンクタイプ別市場

  • 概要
  • 人口に基づくバイオバンク
  • 疾患志向型バイオバンク

第6章 オーナーシップ別市場

  • 概要
  • 国/地域の当局
  • 非営利組織
  • 大学
  • 民間組織

第7章 用途別市場

  • 概要
  • 治療
  • 調査

第8章 地域別市場

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ

第9章 企業プロファイル

  • ASKION GmbH
  • CTI BIOTECH
  • Cureline, Inc.
  • Excilone SARL
  • Firalis S.A.
  • Hamilton Company
  • LabVantage Solutions, Inc.
  • LGC Limited
  • PrecisionMed, Inc.
  • ProMedDx, LLC
図表

List of Tables

  • TABLE 01. BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 02. BLOOD PRODUCTS BIOBANKINGMARKET REVENUE FOR BLOOD PRODUCTS, BY REGION, 2017-2025 ($MILLION)
  • TABLE 03. BIOBANKING MARKET REVENUE FOR SOLID TISSUE, BY REGION, 2017-2025 ($MILLION)
  • TABLE 04. BIOBANKING MARKET REVENUE FOR CELL LINES, BY REGION, 2017-2025 ($MILLION)
  • TABLE 05. BIOBANKING MARKET REVENUE FOR OTHER SAMPLES, BY REGION, 2017-2025 ($MILLION)
  • TABLE 06. BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 07. POPULATION-BASED BIOBANKS MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
  • TABLE 08. DISEASE-ORIENTED BIOBANKS MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
  • TABLE 09. BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 10. BIOBANKING MARKET REVENUE FOR NATIONAL/REGIONAL AGENCY, BY REGION, 2017-2025 ($MILLION)
  • TABLE 11. BIOBANKING MARKET REVENUE FOR NONPROFIT ORGANIZATION, BY REGION, 2017-2025 ($MILLION)
  • TABLE 12. BIOBANKING MARKET REVENUE FOR UNIVERSITY, BY REGION, 2017-2025 ($MILLION)
  • TABLE 13. BIOBANKING MARKET REVENUE FOR PRIVATE ORGANIZATION, BY REGION, 2017-2025 ($MILLION)
  • TABLE 14. BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 15. THERAPEUTIC BIOBANKING MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
  • TABLE 16. RESEARCH BIOBANKING MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
  • TABLE 17. BIOBANKING MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
  • TABLE 18. NORTH AMERICA BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
  • TABLE 19. U.S. BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 20. U.S. BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 21. U.S. BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 22. U.S. BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 23. CANADA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 24. CANADA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 25. CANADA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 26. CANADA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 27. MEXICO BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 28. MEXICO BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 29. MEXICO BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 30. MEXICO BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 31. NORTH AMERICA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 32. NORTH AMERICA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 33. NORTH AMERICA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 34. NORTH AMERICA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 35. EUROPE BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
  • TABLE 36. GERMANY BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 37. GERMANY BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 38. GERMANY BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 39. GERMANY BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 40. FRANCE BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 41. FRANCE BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 42. FRANCE BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 43. FRANCE BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 44. UK BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 45. UK BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 46. UK BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 47. UK BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 48. ITALY BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 49. ITALY BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 50. ITALY BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 51. ITALY BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 52. SPAIN BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 53. SPAIN BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 54. SPAIN BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 55. SPAIN BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 56. REST OF EUROPE BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 57. REST OF EUROPE BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 58. REST OF EUROPE BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 59. REST OF EUROPE BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 60. EUROPE BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 61. EUROPE BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 62. EUROPE BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 63. EUROPE BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 64. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
  • TABLE 65. JAPAN BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 66. JAPAN BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 67. JAPAN BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 68. JAPAN BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 69. CHINA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 70. CHINA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 71. CHINA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 72. CHINA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 73. INDIA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 74. INDIA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 75. INDIA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 76. INDIA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 77. AUSTRALIA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 78. AUSTRALIA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 79. AUSTRALIA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 80. AUSTRALIA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 81. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 82. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 83. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 84. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 85. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 86. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 87. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 88. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 89. LAMEA BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
  • TABLE 90. BRAZIL BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 91. BRAZIL BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 92. BRAZIL BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 93. BRAZIL BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 94. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 95. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 96. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 97. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 98. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 99. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 100. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 101. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 102. REST OF LAMEA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 103. REST OF LAMEA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 104. REST OF LAMEA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 105. REST OF LAMEA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 106. LAMEA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
  • TABLE 107. LAMEA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
  • TABLE 108. LAMEA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
  • TABLE 109. LAMEA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 110. ASKION: COMPANY SNAPSHOT
  • TABLE 111. ASKION: BUSINESS AREAS
  • TABLE 112. ASKION: PRODUCT PORTFOLIO
  • TABLE 113. CTI BIOTECH: COMPANY SNAPSHOT
  • TABLE 114. CTI BIOTECH: PRODUCT PORTFOLIO
  • TABLE 115. CURELINE: COMPANY SNAPSHOT
  • TABLE 116. CURELINE: PRODUCT PORTFOLIO
  • TABLE 117. EXCILONE: COMPANY SNAPSHOT
  • TABLE 118. EXCILONE: BUSINESS AREAS
  • TABLE 119. EXCILONE PRODUCT PORTFOLIO
  • TABLE 120. FIRALIS: COMPANY SNAPSHOT
  • TABLE 121. FIRALIS: OPERATING SEGMENTS
  • TABLE 122. FIRALIS: PRODUCT PORTFOLIO
  • TABLE 123. HAMILTON COMPANY: COMPANY SNAPSHOT
  • TABLE 124. HAMILTON COMPANY: PRODUCT SEGMENTS
  • TABLE 125. HAMILTON COMPANY: PRODUCT PORTFOLIO
  • TABLE 126. LABVANTAGE: COMPANY SNAPSHOT
  • TABLE 127. LABVANTAGE: PRODUCT PORTFOLIO
  • TABLE 128. LGC: COMPANY SNAPSHOT
  • TABLE 129. LGC: OPERATING SEGMENTS
  • TABLE 130. LGC: PRODUCT PORTFOLIO
  • TABLE 131. PRECISIONMED: COMPANY SNAPSHOT
  • TABLE 132. PRECISIONMED: SERVICE PORTFOLIO
  • TABLE 133. PROMEDDX: COMPANY SNAPSHOT
  • TABLE 134. PROMEDDX: PRODUCT PORTFOLIO

List of Figures

  • FIGURE 01. GLOBAL BIOBANKING MARKET SEGMENTATION
  • FIGURE 02. TOP INVESTMENT POCKETS
  • FIGURE 03. IMPACT ANALYSES, 2016
  • FIGURE 04. BIOBANKING MARKET REVENUE FOR BLOOD PRODUCTS, BY COUNTRY, 2017-2025 (%)
  • FIGURE 05. BIOBANKING MARKET REVENUE FOR SOLID TISSUE, BY COUNTRY, 2017-2025 (%)
  • FIGURE 06. BIOBANKING MARKET REVENUE FOR CELL LINES, BY COUNTRY, 2017-2025 (%)
  • FIGURE 07. BIOBANKING MARKET REVENUE FOR OTHER SAMPLES, BY COUNTRY, 2017-2025 (%)
  • FIGURE 08. POPULATION-BASED BIOBANKS REVENUE, BY COUNTRY, 2017-2025 (%)
  • FIGURE 09. DISEASE-ORIENTED BIOBANKS REVENUE, BY COUNTRY, 2017-2025 (%)
  • FIGURE 10. BIOBANKING MARKET REVENUE FOR NATIONAL/REGIONAL AGENCY, BY COUNTRY, 2017-2025 (%)
  • FIGURE 11. BIOBANKING MARKET REVENUE FOR NONPROFIT ORGANIZATION, BY COUNTRY, 2017-2025 (%)
  • FIGURE 12. BIOBANKING MARKET REVENUE FOR UNIVERSITY, BY COUNTRY, 2017-2025 (%)
  • FIGURE 13. BIOBANKING MARKET REVENUE FOR PRIVATE ORGANIZATION, BY COUNTRY, 2017-2025 (%)
  • FIGURE 14. THERAPEUTIC BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 (%)
  • FIGURE 15. RESEARCH BIOBANKING MARKET REVENUE, BY COUNTRY, 2017
目次
Product Code: LI_182798

Title:
Biobanking Market by Specimen Type (Blood products, Solid tissue, and Cell lines), Type of Biobank (Population Based Biobanks, and Disease-Oriented Biobanks), Ownership (National/Regional agencies, Non-profit organization, University, and Private), and Application (Therapeutic, and Research) - Global Opportunity Analysis and Industry Forecast, 2018-2025 .

Biobank is a biorepository meant to collect and preserve biological materials that are used for diagnosis, biodiversity studies, and research. In addition, it is used to support the research of most common types of genetic disorders to develop personalized medicines and to maintain and update age demographic databases.

The global biobanking market garnered $47,062 million in 2016, and is estimated to reach $68,084 million by 2023, growing at a CAGR of 4.6% from 2017 to 2023. Rise in funding by private & government organizations for biobanking and increase in application areas of biobanked samples are the major factors that drive the growth of the global biobanking market. Moreover, upsurge in incidence of diseases such as cancer supports the market growth, owing to the fact that biobanked specimens are used in the treatment of several chronic diseases. However, ethical issues related to biobanking and lack of awareness about it are expected to impede the market growth. On the contrary, advancements in stem cell research and unmet medical needs in the emerging nations are anticipated to provide lucrative opportunity for the market expansion.

The global biobanking market is segmented by specimen type, type of biobank, ownership, application, and region. Based on specimen type, the market is categorized into blood products, solid tissue, cell lines, and others. On the basis of ownership, it is divided into national/regional agencies, nonprofit organization, university, and private. The applications covered in the study include therapeutic and research. Depending on type of biobank, the market is bifurcated into population and disease-oriented biobank. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS

  • This report provides an extensive analysis of the current and emerging trends and dynamics in the global biobanking market to identify the prevailing opportunities.
  • It presents a competitive landscape of the global market to predict the competitive environment across geographies.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Region- and country-wise analyses are provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

By Specimen Type

  • Blood products
  • Solid tissue
  • Cell lines
  • Others

By Application

  • Therapeutic
  • Research

By Type of Biobank

  • Population-based biobanks
  • Disease-oriented biobanks

By Ownership

  • National/regional agencies
  • Nonprofit organization
  • University
  • Private

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

The key players profiled in this report are as follows:

  • ASKION GmbH
  • CTI BIOTECH
  • Cureline, Inc.
  • Excilone SARL
  • Firalis S.A.
  • Hamilton Company
  • LabVantage Solutions, Inc.
  • LGC Limited
  • PrecisionMed, Inc.
  • ProMedDx LLC

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits for stakeholders
  • 1.3. Key market segments
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. Key findings of the study
  • 2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top winning strategies
    • 3.2.2. Top investment pockets
  • 3.3. Top player positioning, 2017
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in funds for biobanks
      • 3.4.1.2. Increase in R&D activities for application of biobank specimens
      • 3.4.1.3. Surge in prevalence of fatal chronic diseases
    • 3.4.2. Restraints
      • 3.4.2.1. Legal and ethical issues
      • 3.4.2.2. Lack of awareness regarding biobanking
    • 3.4.3. Opportunity
      • 3.4.3.1. Untapped opportunities in the developing regions
    • 3.4.4. Impact analyses

CHAPTER 4: BIOBANKING MARKET, BY SPECIMEN TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Blood products
    • 4.2.1. Market size and forecast, by region
    • 4.2.2. Market analysis, by country
  • 4.3. Solid tissues
    • 4.3.1. Market size and forecast, by region
    • 4.3.2. Market analysis, by country
  • 4.4. Cell lines
    • 4.4.1. Market size and forecast, by region
    • 4.4.2. Market analysis, by country
  • 4.5. Others
    • 4.5.1. Market size and forecast, by region
    • 4.5.2. Market analysis, by country

CHAPTER 5: BIOBANKING MARKET, BY TYPE OF BIOBANK

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Population-based biobanks
    • 5.2.1. Market size and forecast, by region
    • 5.2.2. Market analysis, by country
  • 5.3. Disease-oriented biobanks
    • 5.3.1. Market size and forecast, by region
    • 5.3.2. Market analysis, by country

CHAPTER 6: BIOBANKING MARKET, BY OWNERSHIP

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. National/regional agencies
    • 6.2.1. Market size and forecast, by region
    • 6.2.2. Market analysis, by country
  • 6.3. Nonprofit organization
    • 6.3.1. Market size and forecast, by region
    • 6.3.2. Market analysis, by country
  • 6.4. University
    • 6.4.1. Market size and forecast, by region
    • 6.4.2. Market analysis, by country
  • 6.5. Private organization
    • 6.5.1. Market size and forecast, by region
    • 6.5.2. Market analysis, by country

CHAPTER 7: BIOBANKING MARKET, BY APPLICATION

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Therapeutic
    • 7.2.1. Market size and forecast, by region
    • 7.2.2. Market analysis, by country
  • 7.3. Research
    • 7.3.1. Market size and forecast, by region
    • 7.3.2. Market analysis, by country

CHAPTER 8: BIOBANKING MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors, and opportunities
    • 8.2.2. North America market size and forecast, by country
      • 8.2.2.1. U.S. biobanking market size and forecast
      • 8.2.2.1.1. U.S. biobanking market size and forecast, by specimen type
      • 8.2.2.1.2. U.S. biobanking market size and forecast, by type of biobank
      • 8.2.2.1.3. U.S. biobanking market size and forecast, by ownership
      • 8.2.2.1.4. U.S. biobanking market size and forecast, by application
      • 8.2.2.2. Canada biobanking market size and forecast
      • 8.2.2.2.1. Canada biobanking market size and forecast, by specimen type
      • 8.2.2.2.2. Canada biobanking market size and forecast, by type of biobank
      • 8.2.2.2.3. Canada biobanking market size and forecast, by ownership
      • 8.2.2.2.4. Canada biobanking market size and forecast, by application
      • 8.2.2.3. Mexico biobanking market size and forecast
      • 8.2.2.3.1. Mexico biobanking market size and forecast, by specimen type
      • 8.2.2.3.2. Mexico biobanking market size and forecast, by type of biobank
      • 8.2.2.3.3. Mexico biobanking market size and forecast, by ownership
      • 8.2.2.3.4. Mexico biobanking market size and forecast, by application
    • 8.2.3. North America market size and forecast, by specimen type
    • 8.2.4. North America market size and forecast, by type of biobank
    • 8.2.5. North America biobanking market size and forecast, by ownership
    • 8.2.6. North America biobanking market size and forecast, by application
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors, and opportunities
    • 8.3.2. Europe market size and forecast, by country
      • 8.3.2.1. Germany biobanking market size and forecast
      • 8.3.2.1.1. Germany biobanking market size and forecast, by specimen type
      • 8.3.2.1.2. Germany biobanking market size and forecast, by type of biobank
      • 8.3.2.1.3. Germany biobanking market size and forecast, by ownership
      • 8.3.2.1.4. Germany biobanking market size and forecast, by application
      • 8.3.2.2. France biobanking market size and forecast
      • 8.3.2.2.1. France biobanking market size and forecast, by specimen type
      • 8.3.2.2.2. France biobanking market size and forecast, by type of biobank
      • 8.3.2.2.3. France biobanking market size and forecast, by ownership
      • 8.3.2.2.4. France biobanking market size and forecast, by application
      • 8.3.2.3. UK biobanking market size and forecast
      • 8.3.2.3.1. UK biobanking market size and forecast, by specimen type
      • 8.3.2.3.2. UK biobanking market size and forecast, by type of biobank
      • 8.3.2.3.3. UK biobanking market size and forecast, by ownership
      • 8.3.2.3.4. UK biobanking market size and forecast, by application
      • 8.3.2.4. Italy biobanking market size and forecast
      • 8.3.2.4.1. Italy biobanking market size and forecast, by specimen type
      • 8.3.2.4.2. Italy biobanking market size and forecast, by type of biobank
      • 8.3.2.4.3. Italy biobanking market size and forecast, by ownership
      • 8.3.2.4.4. Italy biobanking market size and forecast, by application
      • 8.3.2.5. Spain biobanking market size and forecast
      • 8.3.2.5.1. Spain biobanking market size and forecast, by specimen type
      • 8.3.2.5.2. Spain biobanking market size and forecast, by type of biobank
      • 8.3.2.5.3. Spain biobanking market size and forecast, by ownership
      • 8.3.2.5.4. Spain biobanking market size and forecast, by application
      • 8.3.2.6. Rest of Europe biobanking market size and forecast
      • 8.3.2.6.1. Rest of Europe biobanking market size and forecast, by specimen type
      • 8.3.2.6.2. Rest of Europe biobanking market size and forecast, by type of biobank
      • 8.3.2.6.3. Rest of Europe biobanking market size and forecast, by ownership
      • 8.3.2.6.4. Rest of Europe biobanking market size and forecast, by application
    • 8.3.3. Europe market size and forecast, by specimen type
    • 8.3.4. Europe market size and forecast, by type of biobank
    • 8.3.5. Europe biobanking market size and forecast, by ownership
    • 8.3.6. Europe biobanking market size and forecast, by application
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors, and opportunities
    • 8.4.2. Asia-Pacific market size and forecast, by country
      • 8.4.2.1. Japan biobanking market size and forecast
      • 8.4.2.1.1. Japan biobanking market size and forecast, by specimen type
      • 8.4.2.1.2. Japan biobanking market size and forecast, by type of biobank
      • 8.4.2.1.3. Japan biobanking market size and forecast, by ownership
      • 8.4.2.1.4. Japan biobanking market size and forecast, by application
      • 8.4.2.2. China biobanking market size and forecast
      • 8.4.2.2.1. China biobanking market size and forecast, by specimen type
      • 8.4.2.2.2. China biobanking market size and forecast, by type of biobank
      • 8.4.2.2.3. China biobanking market size and forecast, by ownership
      • 8.4.2.2.4. China biobanking market size and forecast, by application
      • 8.4.2.3. India biobanking market size and forecast
      • 8.4.2.3.1. India biobanking market size and forecast, by specimen type
      • 8.4.2.3.2. India biobanking market size and forecast, by type of biobank
      • 8.4.2.3.3. India biobanking market size and forecast, by ownership
      • 8.4.2.3.4. India biobanking market size and forecast, by application
      • 8.4.2.4. Australia biobanking market size and forecast
      • 8.4.2.4.1. Australia biobanking market size and forecast, by specimen type
      • 8.4.2.4.2. Australia biobanking market size and forecast, by type of biobank
      • 8.4.2.4.3. Australia biobanking market size and forecast, by ownership
      • 8.4.2.4.4. Australia biobanking market size and forecast, by application
      • 8.4.2.5. Rest of Asia-Pacific biobanking market size and forecast
      • 8.4.2.5.1. Rest of Asia-Pacific biobanking market size and forecast, by specimen type
      • 8.4.2.5.2. Rest of Asia-Pacific biobanking market size and forecast, by type of biobank
      • 8.4.2.5.3. Rest of Asia-Pacific biobanking market size and forecast, by ownership
      • 8.4.2.5.4. Rest of Asia-Pacific biobanking market size and forecast, by application
    • 8.4.3. Asia-Pacific market size and forecast, by specimen type
    • 8.4.4. Asia-Pacific market size and forecast, by type of biobank
    • 8.4.5. Asia-Pacific biobanking market size and forecast, by ownership
    • 8.4.6. Asia-Pacific biobanking market size and forecast, by application
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors, and opportunities
    • 8.5.2. LAMEA market size and forecast, by country
      • 8.5.2.1. Brazil biobanking market size and forecast
      • 8.5.2.1.1. Brazil biobanking market size and forecast, by specimen type
      • 8.5.2.1.2. Brazil biobanking market size and forecast, by type of biobank
      • 8.5.2.1.3. Brazil biobanking market size and forecast, by ownership
      • 8.5.2.1.4. Brazil biobanking market size and forecast, by application
      • 8.5.2.2. South Africa biobanking market size and forecast
      • 8.5.2.2.1. South Africa biobanking market size and forecast, by specimen type
      • 8.5.2.2.2. South Africa biobanking market size and forecast, by type of biobank
      • 8.5.2.2.3. South Africa biobanking market size and forecast, by ownership
      • 8.5.2.2.4. South Africa biobanking market size and forecast, by application
      • 8.5.2.3. Saudi Arabia biobanking market size and forecast
      • 8.5.2.3.1. Saudi Arabia biobanking market size and forecast, by specimen type
      • 8.5.2.3.2. Saudi Arabia biobanking market size and forecast, by type of biobank
      • 8.5.2.3.3. Saudi Arabia biobanking market size and forecast, by ownership
      • 8.5.2.3.4. Saudi Arabia biobanking market size and forecast, by application
      • 8.5.2.4. Rest of LAMEA biobanking market size and forecast
      • 8.5.2.4.1. Rest of LAMEA biobanking market size and forecast, by specimen type
      • 8.5.2.4.2. Rest of LAMEA biobanking market size and forecast, by type of biobank
      • 8.5.2.4.3. Rest of LAMEA biobanking market size and forecast, by ownership
      • 8.5.2.4.4. Rest of LAMEA biobanking market size and forecast, by application
    • 8.5.3. LAMEA market size and forecast, by specimen type
    • 8.5.4. LAMEA market size and forecast, by type of biobank
    • 8.5.5. LAMEA biobanking market size and forecast, by ownership
    • 8.5.6. LAMEA biobanking market size and forecast, by application

CHAPTER 9: COMPANY PROFILES

  • 9.1. ASKION GmbH
    • 9.1.1. Company overview
    • 9.1.2. Company snapshot
    • 9.1.3. Operating business segments
    • 9.1.4. Product portfolio
  • 9.2. CTI BIOTECH
    • 9.2.1. Company overview
    • 9.2.2. Company snapshot
    • 9.2.3. Product portfolio
  • 9.3. Cureline, Inc.
    • 9.3.1. Company overview
    • 9.3.2. Company snapshot
    • 9.3.3. Product portfolio
  • 9.4. Excilone SARL
    • 9.4.1. Company overview
    • 9.4.2. Company snapshot
    • 9.4.3. Operating business segments
    • 9.4.4. Product portfolio
  • 9.5. Firalis S.A.
    • 9.5.1. Company overview
    • 9.5.2. Company snapshot
    • 9.5.3. Operating business segments
    • 9.5.4. Product portfolio
  • 9.6. Hamilton Company
    • 9.6.1. Company overview
    • 9.6.2. Company snapshot
    • 9.6.3. Operating business segments
    • 9.6.4. Product portfolio
  • 9.7. LabVantage Solutions, Inc.
    • 9.7.1. Company overview
    • 9.7.2. Company snapshot
    • 9.7.3. Product portfolio
    • 9.7.4. Key strategic moves and developments
  • 9.8. LGC Limited
    • 9.8.1. Company overview
    • 9.8.2. Company snapshot
    • 9.8.3. Operating business segments
    • 9.8.4. Product portfolio
    • 9.8.5. Business performance
  • 9.9. PrecisionMed, Inc.
    • 9.9.1. Company overview
    • 9.9.2. Company snapshot
    • 9.9.3. Product portfolio
  • 9.10. ProMedDx, LLC
    • 9.10.1. Company overview
    • 9.10.2. Company snapshot
    • 9.10.3. Product portfolio
Back to Top